RN7SL835P

Across TCGA pan-cancer cohorts, RN7SL835P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RN7SL835P’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RN7SL835P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL835P is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.

LUAD, LUSC, and KIRC are the cancer types where RN7SL835P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL835P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	IV	−0.464	<.001	11	view →
LUSC	Female	All	−0.378	<.001	6	view →
KIRC	Female	IV	−0.271	.010	3	view →
THCA	All	All	+0.181	.017	3	view →
KIRP	All	All	−0.259	.008	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RN7SL835P–LUAD

Open the LUAD breakdown →